Zachary Tracer, Business Insider

Zachary Tracer

Business Insider

New York, NY, United States

Contact Zachary

Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.

Start free trial

Recent:
  • Unknown
Past:
  • Business Insider
  • BQ Prime
  • Bloomberg
  • Washington Post
  • BenefitsPro.com
  • Inside Scoop SF
  • Houston Chronicle

Past articles by Zachary:

We got an exclusive look at the presentation that Cedar used to convince investors like Andreessen Horowitz to bet on the startup's vision of a better way of paying for healthcare

Here's how Cedar won over investors in 2020 by pitching them on its approach to making the medical billing experience simpler for patients. → Read More

We got an exclusive look at the presentation that a former casino exec used to convince investors to bet $40 million on a new way of helping companies take care of their workers

The startup was founded by a former Caesar's Entertainment executive and uses a reward system similar to that of gambling to get its users active. → Read More

2 charts from a top Wall Street bank reveal how drugmakers could deliver a coronavirus vaccine October surprise for Trump

We could get data showing that an experimental coronavirus vaccine works right before the election. → Read More

RBC shares 7 healthcare stocks to buy now to prepare for a Biden victory — and 3 that could surge even if Trump triumphs

Biden wants to give more people health insurance and force drug companies to lower some prices. → Read More

US health authorities will allow emergency use of Gilead's coronavirus treatment

The coronavirus treatment just succeeded in a critical trial, helping severe COVID-19 patients recover faster. → Read More

Bill Gates shares the 5 key innovations that are crucial to overcoming the coronavirus pandemic

Bill Gates says we need new discoveries in areas including treatments and vaccines to beat the coronavirus. → Read More

We spoke to the man in charge of innovation at a $29 billion hospital system. He laid out the 4 places he's looking to place his bets.

CommonSpirit runs 142 hospitals across the US, and Roth is looking for ways of helping the system do a better job of caring for its patients. → Read More

'Natural buzz' for Goldman Sachs, Job hunting at McKinsey and Netflix, and investigating a tech CEO's unexplained death

Here are the business stories you need to read this week, including news on Goldman Sachs, Schwab, and a tech CEO's unexplained death. → Read More

Ancestry just came out with 2 new DNA tests focused on health. Here’s what you can learn from them.

Ancestry's new products will test for heart conditions, inherited cancers, and carrier status for conditions like cystic fibrosis. → Read More

Walmart is opening health clinics, but that’s just the start. We got the full story from the exec leading its push into the $3.5 trillion US healthcare industry.

"Walmart is a sleeping giant, and they're putting together all the pieces to be able to move big in healthcare," Dr. Lisa Bielamowicz said. → Read More

CVS just decided against selling uBiome's poop-testing kits, dealing another blow to the bankrupt startup

"Given the circumstances surrounding uBiome, we'll be stopping shipments and, in the event product has already arrived in store, marking it as 'do not sell,'" a CVS spokesperson said. → Read More

Dispensed: Young blood startup is back, a scoop about CityMD, and telling remarks from Merck's CEO

Welcome to Dispensed, our weekly dispatch of healthcare, biotech, and pharma news from Business Insider. → Read More

Air New Zealand sells an unusual economy seat that can turn into a couch. Here's why they are a bit disappointing but still worth it.

On a 12-hour flight, it's nice not to sit next to a stranger. This is where Air New Zealand's Skycouch comes in handy. → Read More

Walmart and CVS just resolved their $4 billion dispute over where you can pick up your prescriptions

People whose prescriptions are handled by CVS Caremark will still be able to pick them up at Walmart pharmacies, after the companies ended a pricing spat. → Read More

We'll get you caught up on all the news you missed at the year's biggest healthcare investor conference

Among the highlights: an $8 billion deal (and more to come?), a promising depression drug, and a strategy deep dive from a healthcare giant. → Read More

A $72 billion Canadian investor is poised to start making venture capital bets in Silicon Valley

One of Canada's biggest pension funds is expanding to Silicon Valley as it seeks to place bets on startups in fields like healthcare and transportation. → Read More

2 retail giants are feuding over prescription drugs and it *signals* a 'seismic shift' for the future of healthcare

CVS and Walmart are trading blame after the pharmacy giant said some customers could no longer pick up their prescriptions at Walmart stores. → Read More

5 big biotech losers from JPMorgan's massive healthcare conference

These are the five biotech stocks that had big tumbles during the annual JPMorgan healthcare conference this week. → Read More

CVS Health just revealed a key piece of its plan to change how Americans get healthcare

In a presentation Tuesday, CVS CEO Larry Merlo outlined how the company is going to take to see if they can influence how healthcare is used. → Read More

Obamacare sign ups fell only slightly this year, despite Trump, GOP efforts to undermine the health law

The number of people signing up for Obamacare plans dropped this year amid an improving economy and uncertainty caused by President Donald Trump and the GOP's changes. → Read More